Literature DB >> 33108495

Prognostic implications of pre-existing medical comorbidity in Takotsubo cardiomyopathy.

Arash Nayeri1, Alexander Yuen2, Cher Huang2, Kathryn Cardoza3, Kamran Shamsa2, Boback Ziaeian, Quinn S Wells4,5, Gregg Fonarow2, Tamara Horwich2.   

Abstract

Takotsubo cardiomyopathy (TC) is associated with significant short-term morbidity and mortality. Several risk factors for poor outcomes have been identified; however, the prognostic implications of pre-existing comorbidity in TC are poorly delineated. We sought to assess the association of aggregate pre-existing comorbidity with short-term outcomes in TC. We performed a retrospective observational study of adult subjects diagnosed with TC at two academic tertiary care hospitals between 2005 and 2018. Overall burden of medical comorbidity was estimated using the Charlson comorbidity index (CCI). Multivariable logistic regression was used to test for independent association of CCI with 30-day mortality and severe shock at index presentation. Multivariable poisson regression was performed to assess the association of CCI with duration of hospitalization. Five-hundred and thirty-eight subjects were diagnosed with TC during the study period. The median CCI score of all subjects was 2 (IQR 1-4). Among subjects with physical triggers of TC, the median CCI score was 2 (IQR 1-4) compared to a median CCI score of 1 (IQR 0-1) in subjects with non-physical triggers of TC (P < 0.001). Seventy-six (14%) subjects died within 30 days of index diagnosis and 185 (34%) subjects experienced severe shock. The median duration of hospitalization was 7 days (IQR 3-14 days). In multivariable logistic regression, CCI was not associated with 30-day mortality or severe shock. In multivariable Poisson regression, CCI (IRR 1.17, 95% CI 1.16-1.18, P < 0.001) was associated with duration of hospitalization. Increased burden of pre-existing medical comorbidity was not independently associated with 30-day mortality or severe shock at index presentation, but was associated with increased duration of hospitalization after diagnosis of TC.

Entities:  

Keywords:  Charlson comorbidity index; Comorbidity; Mortality; Shock; Stress cardiomyopathy; Takotsubo

Mesh:

Year:  2020        PMID: 33108495      PMCID: PMC7946705          DOI: 10.1007/s00380-020-01713-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  3 in total

1.  Comorbidity in heart failure. Results of the Spanish RICA Registry.

Authors:  F-J Ruiz-Laiglesia; M Sánchez-Marteles; J-I Pérez-Calvo; F Formiga; J A Bartolomé-Satué; A Armengou-Arxé; R López-Quirós; J Pérez-Silvestre; A Serrado-Iglesias; M Montero-Pérez-Barquero
Journal:  QJM       Date:  2014-06-16

2.  Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012.

Authors:  Dragana Radovanovic; Burkhardt Seifert; Philip Urban; Franz R Eberli; Hans Rickli; Osmund Bertel; Milo A Puhan; Paul Erne
Journal:  Heart       Date:  2013-11-01       Impact factor: 5.994

3.  Comparison and Outcome Analysis of Patients with Takotsubo Cardiomyopathy Triggered by Emotional Stress or Physical Stress.

Authors:  Giannakopoulos Konstantinos; Ibrahim El-Battrawy; Katja Schramm; Ansari Uzair; Ursula Hoffmann; Borggrefe Martin; Akin Ibrahim
Journal:  Front Psychol       Date:  2017-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.